0910-AF98 200710 The Regulatory Plan and the Unified Agenda of Federal Regulatory and Deregulatory Actions 0910 Food and Drug Administration FDA 0900 Department of Health and Human Services HHS Human Cells, Tissues, and Cellular and Tissue-Based Products; Donor Screening and Testing, and Related Labeling The Food and Drug Administration (FDA) is issuing a final rule, after issuing an interim final rule that amended certain regulations regarding the screening and testing of donors of human cells, tissues, and cellular and tissue-based products (HCT/Ps) and related labeling. FDA is taking this action to complete the rulemaking initiated with the interim final rule. Other Significant Previously Published in The Unified Agenda Completed Actions No No 21 CFR 1271.55 21 CFR 1271.80 21 CFR 1271.90 21 CFR 1271.290 21 CFR 1271.370 42 USC 264 No Interim Final Rule 05/25/2005 70 FR 29949 Final Action 06/19/2007 72 FR 33667 No No None No No Not Collected Brenda Friend 0910 Food and Drug Administration FDA 301 827-6210 Center for Biologics Evaluation and Research, 1401 Rockville Pike, Suite 200N (HFM-17), Rockville MD 20852-1448